Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Cervical Cancer, July 2019

Free Subscription


Abstracts

Retrieve all available abstracts of the following 246 articles:
HTML format


 

Single Articles

  1. CHAO YS, Clark M, Carson E, Weeks L, et al
    Estimation of the Costs of Invasive Cervical Cancer Treatment in Brazil: A Micro-Costing Study.
    Rev Bras Ginecol Obstet. 2019;41:387-393.
    Abstract    

    Abstract available

  2. CHEN J, Deng Y, Ao L, Song Y, et al
    The high-risk HPV oncogene E7 upregulates miR-182 expression through the TGF-beta/Smad pathway in cervical cancer.
    Cancer Lett. 2019 Jun 24. pii: S0304-3835(19)30376.
    Abstract    

    Abstract available

  3. HUCHKO MJ, Saduma I, Blat C, Oketch S, et al
    How Providing Cervical Cancer Screening Results via Cell Phone Affects Patient Follow-Up Rates in Western Kenya.
    J Glob Oncol. 2019;5:1-8.
    Abstract    

    Abstract available

  4. TAGHIZADEH E, Jahangiri S, Rostami D, Taheri F, et al
    Role of E6 and E7 Human Papillomavirus Proteins in Molecular Pathogenesis of Cervical Cancer.
    Curr Protein Pept Sci. 2019 Jun 17. pii: CPPS-EPUB-98921.
    Abstract    

    Abstract available

  5. YUDHANI RD, Astuti I, Mustofa M, Indarto D, et al
    Metformin Modulates Cyclin D1 and P53 Expression to Inhibit Cell Proliferation and to Induce Apoptosis in Cervical Cancer Cell Lines.
    Asian Pac J Cancer Prev. 2019;20:1667-1673.
    Abstract    

    Abstract available

  6. CHEN X, Wei S, Ma H, Jin G, et al
    Telomere length in cervical exfoliated cells, interaction with HPV genotype, and cervical cancer occurrence among high-risk HPV-positive women.
    Cancer Med. 2019 Jun 26. doi: 10.1002/cam4.2246.
    Abstract    

    Abstract available

  7. BUTTARELLI M, Babini G, Raspaglio G, Filippetti F, et al
    A combined ANXA2-NDRG1-STAT1 gene signature predicts response to chemoradiotherapy in cervical cancer.
    J Exp Clin Cancer Res. 2019;38:279.
    Abstract    

    Abstract available

  8. CHAICHIAN S, Shafabakhsh R, Mirhashemi SM, Moazzami B, et al
    Circular RNAs: A novel biomarker for cervical cancer.
    J Cell Physiol. 2019 Jun 25. doi: 10.1002/jcp.29009.
    Abstract    

    Abstract available

  9. LI S, Liu S, Ratcliffe J, Gray A, et al
    Preferences for cervical cancer screening service attributes in rural China: a discrete choice experiment.
    Patient Prefer Adherence. 2019;13:881-889.
    Abstract    

    Abstract available

  10. XU Z, Traughber BJ, Fredman E, Albani D, et al
    Appropriate Methodology for EBRT and HDR Intracavitary/Interstitial Brachytherapy Dose Composite and Clinical Plan Evaluation for Patients with Cervical Cancer.
    Pract Radiat Oncol. 2019 Jun 22. pii: S1879-8500(19)30165.
    Abstract    

    Abstract available

  11. SHIN YB, Choi WJ, Kim C
    Radiation-induced cutaneous angiosarcoma of the abdomen in a patient with cervical cancer: A case report.
    J Obstet Gynaecol Res. 2019 Jun 25. doi: 10.1111/jog.14034.
    Abstract    

    Abstract available

  12. SAWADA M, Oishi T, Komatsu H, Sato S, et al
    Serum vascular endothelial growth factor A and vascular endothelial growth factor receptor 2 as prognostic biomarkers for uterine cervical cancer.
    Int J Clin Oncol. 2019 Jun 24. pii: 10.1007/s10147-019-01495.
    Abstract    

    Abstract available

  13. SU PH, Lai HC, Huang RL, Chen LY, et al
    Paired Box-1 (PAX1) Activates Multiple Phosphatases and Inhibits Kinase Cascades in Cervical Cancer.
    Sci Rep. 2019;9:9195.
    Abstract    

    Abstract available

  14. LEUNG TH, Tang HW, Siu MK, Chan DW, et al
    CD71(+) population enriched by HPV-E6 protein promotes cancer aggressiveness and radioresistance in cervical cancer cells.
    Mol Cancer Res. 2019 Jun 24. pii: 1541-7786.MCR-19-0068.
    Abstract    

    Abstract available

  15. MCCLYMONT E, Lee M, Elwood C, Mitchell-Foster S, et al
    Cervical Cancer Screening in Immunocompromised Women.
    J Obstet Gynaecol Can. 2019 Jun 22. pii: S1701-2163(19)30275.
    Abstract    



  16. LI Q, Zhang Y, Jiang Q
    SETD3 reduces KLC4 expression to improve the sensitization of cervical cancer cell to radiotherapy.
    Biochem Biophys Res Commun. 2019 Jun 21. pii: S0006-291X(19)31194.
    Abstract    

    Abstract available

  17. OLUSOLA P, Banerjee HN, Philley JV, Dasgupta S, et al
    Human Papilloma Virus-Associated Cervical Cancer and Health Disparities.
    Cells. 2019;8.
    Abstract    

    Abstract available

  18. XU J, Zhang J
    LncRNA TP73-AS1 is a novel regulator in cervical cancer via miR-329-3p/ARF1 axis.
    J Cell Biochem. 2019 Jun 24. doi: 10.1002/jcb.29181.
    Abstract    

    Abstract available

  19. CEYHAN GUVENSEN N, Keskin D, Gunes H, Kesik Oktay M, et al
    Antimicrobial property and antiproliferative activity of Centaurea babylonica (L.) L. on human carcinomas and cervical cancer cell lines.
    Ann Agric Environ Med. 2019;26:290-297.
    Abstract    

    Abstract available

  20. CHOPRA S, Mittal P, Viswanathan A, Tharavichitkul E, et al
    Global Collaborations for Cervical Cancer: Can the East-West Alliance Facilitate Treatment for all?
    Clin Oncol (R Coll Radiol). 2019 Jun 19. pii: S0936-6555(19)30248.
    Abstract    

    Abstract available

  21. CHAN DNS, So WKW, Choi KC, Gurung S, et al
    Development of an explanatory model to explore cervical cancer screening behaviour among South Asian women: The influence of multilevel factors.
    Eur J Oncol Nurs. 2019;40:2-9.
    Abstract    

    Abstract available

  22. ESPENEL S, Limkin E, Garcia MA, Langrand-Escure J, et al
    [Brachytherapy: When needs overtake care offer].
    Bull Cancer. 2019;106:584-589.
    Abstract    

    Abstract available

  23. BLIDARU A, Bordea C, Burcos T, Dudus L, et al
    Mind the Gap Between Scientific Literature Recommendations and Effective Implementation. Is There Still a Role for Surgery in the Treatment of Locally Advanced Cervical Carcinoma?
    Chirurgia (Bucur). 2019;114:18-28.
    Abstract    

    Abstract available

  24. DUZGUNES N, Cheung J, Konopka K
    Suicide Gene Therapy of Oral Squamous Cell Carcinoma and Cervical Carcinoma In Vitro.
    Methods Mol Biol. 2019;1895:177-184.
    Abstract    

    Abstract available

  25. SUN H, Lin T, Xie K, Gao L, et al
    Imaging study of pseudo-CT images of superposed ultrasound deformation fields acquired in radiotherapy based on step-by-step local registration.
    Med Biol Eng Comput. 2019;57:643-651.
    Abstract    

    Abstract available

  26. SNIADECKI M, Swierzko A, Dabkowski M, Orlowska-Volk M, et al
    New therapeutic approaches in the treatment of node-positive cervical cancer patients based on molecular targets: a systematic review.
    Ginekol Pol. 2019;90:336-345.
    Abstract    

    Abstract available

  27. LEI C, Ma S, Huang M, An J, et al
    Long-Term Survival and Late Toxicity Associated With Pelvic Intensity Modulated Radiation Therapy (IMRT) for Cervical Cancer Involving CT-Based Positive Lymph Nodes.
    Front Oncol. 2019;9:520.
    Abstract    

    Abstract available

  28. LIU Z, Shi H
    Prognostic Role of Squamous Cell Carcinoma Antigen in Cervical Cancer: A Meta-analysis.
    Dis Markers. 2019;2019:6710352.
    Abstract    

    Abstract available

  29. SONG H, Liu Y, Jin X, Liu Y, et al
    Long non-coding RNA LINC01535 promotes cervical cancer progression via targeting the miR-214/EZH2 feedback loop.
    J Cell Mol Med. 2019 Jul 5. doi: 10.1111/jcmm.14476.
    Abstract    

    Abstract available

  30. YAMAZAKI H, Nakamura T, Otsuki Y, Tsuchiya M, et al
    Correction to: Sudden fatal bleeding from a uretero-arterial fistula combined with pre-existing uretero-colic and uretero-vaginal fistulas 7 years after a cervical cancer surgery: a case report.
    Surg Case Rep. 2019;5:108.
    Abstract    

    Abstract available

  31. YANG Z, Wu JR, Wei LL, Liao GX, et al
    High standardized uptake values of (18)F-FDG PET/CT imaging but not MRI correlates to pathology findings in patients with cervical cancer.
    Hell J Nucl Med. 2019 Jul 7. pii: s002449911001. doi: 10.1967/s002449911001.
    Abstract    

    Abstract available

  32. TANIGUCHI M, Ueda Y, Yagi A, Ikeda S, et al
    Cervical cancer screening rate differs by HPV vaccination status: An interim analysis.
    Vaccine. 2019 Jul 1. pii: S0264-410X(19)30839.
    Abstract    

    Abstract available

  33. MA YL, Zhang YS, Zhang F, Zhang YY, et al
    Methyl protodioscin from Polygonatum sibiricum inhibits cervical cancer through cell cycle arrest and apoptosis induction.
    Food Chem Toxicol. 2019 Jul 1:110655. doi: 10.1016/j.fct.2019.110655.
    Abstract    

    Abstract available

  34. WANG J, Su Y, Tian Y, Ding Y, et al
    Characterization of DNA hydroxymethylation profile in cervical cancer.
    Artif Cells Nanomed Biotechnol. 2019;47:2706-2714.
    Abstract    

    Abstract available

  35. JAGT TZ, Breedveld S, van Haveren R, Nout RA, et al
    Plan-library supported automated replanning for online-adaptive intensity-modulated proton therapy of cervical cancer.
    Acta Oncol. 2019 Jul 4:1-6. doi: 10.1080/0284186X.2019.1627414.
    Abstract    

    Abstract available

  36. HSIAO YH, Lin CW, Wang PH, Hsin MC, et al
    The Potential of Chinese Herbal Medicines in the Treatment of Cervical Cancer.
    Integr Cancer Ther. 2019;18:1534735419861693.
    Abstract    

    Abstract available

  37. SONG Y, Guo Q, Gao S, Hua K, et al
    miR-454-3p promotes proliferation and induces apoptosis in human cervical cancer cells by targeting TRIM3.
    Biochem Biophys Res Commun. 2019 Jun 30. pii: S0006-291X(19)31264.
    Abstract    

    Abstract available

  38. AMENGUAL J, Montano J, Franch P, Ramos M, et al
    [Survival by cervical cancer stage and factors collected by the Cancer Registry in Mallorca (Spain)].
    Gac Sanit. 2019 Jun 30. pii: S0213-9111(19)30118.
    Abstract    

    Abstract available

  39. WHITNEY RV
    An Intimate Conversation About Cervical Cancer: Ten Lessons Along the Journey.
    J Palliat Med. 2019;22:865-867.
    Abstract    



  40. KAPORA E, Feng S, Liu W, Sakhautdinova I, et al
    MicroRNA-505-5p functions as a tumor suppressor by targeting Cyclin-Dependent Kinase 5 in cervical cancer.
    Biosci Rep. 2019 Jul 2. pii: BSR20191221. doi: 10.1042/BSR20191221.
    Abstract    

    Abstract available

  41. ZHANG H, Li Y, Li M, Chen X, et al
    A randomized controlled trial of mindfulness-based stress reduction for insomnia secondary to cervical cancer: Sleep effects.
    Appl Nurs Res. 2019;48:52-57.
    Abstract    

    Abstract available

  42. ESPENEL S, Garcia MA, Langrand-Escure J, Vallard A, et al
    Special Focus on Stage IV Cervical Cancer Patients: A Decade Experience.
    Oncology. 2019 Jul 2:1-10. doi: 10.1159/000500025.
    Abstract    

    Abstract available

  43. BENARD VB, Greek A, Jackson JE, Senkomago V, et al
    Overview of Centers for Disease Control and Prevention's Case Investigation of Cervical Cancer Study.
    J Womens Health (Larchmt). 2019 Jul 2. doi: 10.1089/jwh.2019.7849.
    Abstract    

    Abstract available

  44. LIN W, Wang Y, Liu Z, Chen B, et al
    Awareness and Attitude towards Human Papillomavirus and Its Vaccine among Females with and without Daughter(s) Who Participated in Cervical Cancer Screening in Shenzhen, China.
    Trop Med Int Health. 2019 Jul 2. doi: 10.1111/tmi.13283.
    Abstract    

    Abstract available

  45. KIM H, Mahmood A, Carlton E, Goldsmith J, et al
    Access to Personal Health Records and Screening for Breast and Cervical Cancer Among Women with a Family History of Cancer.
    J Cancer Educ. 2019 Jul 1. pii: 10.1007/s13187-019-01568.
    Abstract    

    Abstract available

  46. AYHAN A, Aslan K, Oz M, Tohma YA, et al
    Para-aortic lymph node involvement revisited in the light of the revised 2018 FIGO staging system for cervical cancer.
    Arch Gynecol Obstet. 2019 Jul 1. pii: 10.1007/s00404-019-05232.
    Abstract    

    Abstract available

  47. CHEN XJ, Deng YR, Wang ZC, Wei WF, et al
    Hypoxia-induced ZEB1 promotes cervical cancer progression via CCL8-dependent tumour-associated macrophage recruitment.
    Cell Death Dis. 2019;10:508.
    Abstract    

    Abstract available


  48. Clinical outcomes in cervical cancer patients treated by FDG-PET/CT-based 3-dimensional planning for the first brachytherapy session: Erratum.
    Medicine (Baltimore). 2019;98:e16336.
    Abstract    



  49. KASHYAP N, Krishnan N, Kaur S, Ghai S, et al
    Risk Factors of Cervical Cancer: A Case-Control Study.
    Asia Pac J Oncol Nurs. 2019;6:308-314.
    Abstract    

    Abstract available

  50. HUNG WC, Wu TF, Ng SC, Lee YC, et al
    Involvement of endothelial nitric oxide synthase gene variants in the aggressiveness of uterine cervical cancer.
    J Cancer. 2019;10:2594-2600.
    Abstract    

    Abstract available

  51. CHAMBUSO R, Ramesar R, Kaambo E, Denny L, et al
    Human Leukocyte Antigen (HLA) Class II -DRB1 and -DQB1 Alleles and the Association with Cervical Cancer in HIV/HPV Co-Infected Women in South Africa.
    J Cancer. 2019;10:2145-2152.
    Abstract    

    Abstract available

  52. JIA L, Hu Y, Yang G, Li P, et al
    Puerarin suppresses cell growth and migration in HPV-positive cervical cancer cells by inhibiting the PI3K/mTOR signaling pathway.
    Exp Ther Med. 2019;18:543-549.
    Abstract    

    Abstract available

  53. JIAO J, Zhang T, Jiao X, Huang T, et al
    hsa_circ_0000745 promotes cervical cancer by increasing cell proliferation, migration, and invasion.
    J Cell Physiol. 2019 Jun 29. doi: 10.1002/jcp.29045.
    Abstract    

    Abstract available

  54. HSU W, Liu L, Chen X, Zhang Y, et al
    LncRNA CASC11 promotes the cervical cancer progression by activating Wnt/beta-catenin signaling pathway.
    Biol Res. 2019;52:33.
    Abstract    

    Abstract available

  55. JIN G, Fan XM, Li KX, Niu SH, et al
    The Association between Epidermal Growth Factor Receptor Single Nucleotide Polymorphisms and Radiochemotherapy Response in Cervical Cancer.
    Pathol Oncol Res. 2019 Jun 28. pii: 10.1007/s12253-019-00690.
    Abstract    

    Abstract available

  56. CHANG S, Sun L, Feng G
    SP1-mediated long noncoding RNA POU3F3 accelerates the cervical cancer through miR-127-5p/FOXD1.
    Biomed Pharmacother. 2019;117:109133.
    Abstract    

    Abstract available

  57. TSUCHIDA K, Murakami N, Kato T, Okuma K, et al
    Postoperative pelvic intensity-modulated radiation therapy reduced the incidence of late gastrointestinal complications for uterine cervical cancer patients.
    J Radiat Res. 2019 Jun 28. pii: 5524789. doi: 10.1093.
    Abstract    

    Abstract available

  58. GUPTA MK, Kushwah AS, Singh R, Banerjee M, et al
    Genotypic analysis of XRCC4 and susceptibility to cervical cancer.
    Br J Biomed Sci. 2019 Jun 28. pii: 10.1080/09674845.2019.1637573.
    Abstract    

    Abstract available

  59. CHEN C, Li HF, Hu YJ, Jiang MJ, et al
    Family with Sequence Similarity 83 Member H Promotes the Viability and Metastasis of Cervical Cancer Cells and Indicates a Poor Prognosis.
    Yonsei Med J. 2019;60:611-618.
    Abstract    

    Abstract available

  60. WEI S, Dai P, Wang Z
    Cervical Cancer Detection and Diagnosis Based on Saliency Single Shot MultiBox Detector in Ultrasonic Elastography.
    J Med Syst. 2019;43:250.
    Abstract    

    Abstract available

  61. NAGAPOOSANAM AL, Ganesan N, Umapathy D, Moorthy RK, et al
    Knockdown of human telomerase reverse transcriptase induces apoptosis in cervical cancer cell line.
    Indian J Med Res. 2019;149:345-353.
    Abstract    

    Abstract available

  62. TORJESEN I
    HPV vaccine: high coverage could eradicate cervical cancer within decades, say researchers.
    BMJ. 2019;365:l4450.
    Abstract    



  63. NAIZHAER G, Kuerban A, Meilipa, Kuerban R, et al
    Up-regulation of lncRNA FALEC indicates prognosis and diagnosis values in cervical cancer.
    Pathol Res Pract. 2019 Jun 15:152495. doi: 10.1016/j.prp.2019.152495.
    Abstract    

    Abstract available

  64. CHAO YS, Clark M, Carson E, Weeks L, et al
    Correlation between integration of high-risk HPV genome into human DNA detected by molecular combing and the severity of cervical lesions: first results of the EXPL-HPV-002 study.
    Ceska Gynekol. 2019;84:84-92.
    Abstract    

    Abstract available

  65. JULLIAN O, Darquy S, Moutel G, Duchange N, et al
    [Ethical considerations in the evolution of organised cancer screening programs].
    Rev Prat. 2019;69:107-109.
    Abstract    

    Abstract available

  66. DE BELS F, Barre S, Catajar N, Le Bail M, et al
    [French national cancer screening programs: What does the future hold?]
    Rev Prat. 2019;69:102-106.
    Abstract    

    Abstract available

  67. GAUDELUS J
    [Vaccination against papillomavirus: assessment and new indications].
    Rev Prat. 2019;69:7-12.
    Abstract    



  68. XIANG X, Luo L, Nodzynski M, Li C, et al
    LION: a simple and rapid method to achieve CRISPR gene editing.
    Cell Mol Life Sci. 2019;76:2633-2645.
    Abstract    

    Abstract available

  69. ZHANG B, Yang Y, Ding L, Moser MAJ, et al
    Tumor Ablation Enhancement by Combining Radiofrequency Ablation and Irreversible Electroporation: An In Vitro 3D Tumor Study.
    Ann Biomed Eng. 2019;47:694-705.
    Abstract    

    Abstract available

  70. GAD MM, Galal SB, Helmy W, Abd El-Fattah NH, et al
    Screening of Cervical Cancer: Visual Inspection with Acetic Acid (VIA) and Site of Lesion Verified by Multiple Punch Biopsies.
    Folia Med (Plovdiv). 2019;61:289-295.
    Abstract    

    Abstract available

  71. FIGUEIREDO J, Lopes-Nunes J, Carvalho J, Antunes F, et al
    AS1411 derivatives as carriers of G-quadruplex ligands for cervical cancer cells.
    Int J Pharm. 2019 Jul 10:118511. doi: 10.1016/j.ijpharm.2019.118511.
    Abstract    

    Abstract available

  72. CAMPOS-ROMERO A, Anderson KS, Longatto-Filho A, Luna-Ruiz Esparza MA, et al
    The burden of 14 hr-HPV genotypes in women attending routine cervical cancer screening in 20 states of Mexico: a cross-sectional study.
    Sci Rep. 2019;9:10094.
    Abstract    

    Abstract available

  73. VISSER J, de Boer P, Crama KF, van Kesteren Z, et al
    Dosimetric comparison of library of plans and online MRI-guided radiotherapy of cervical cancer in the presence of intrafraction anatomical changes.
    Radiat Oncol. 2019;14:126.
    Abstract    

    Abstract available

  74. QURESHI SA, Gele A, Kour P, Moen KA, et al
    A community-based intervention to increase participation in cervical cancer screening among immigrants in Norway.
    BMC Med Res Methodol. 2019;19:147.
    Abstract    

    Abstract available

  75. SUN XY, Han XM, Zhao XL, Cheng XM, et al
    MiR-93-5p promotes cervical cancer progression by targeting THBS2/MMPS signal pathway.
    Eur Rev Med Pharmacol Sci. 2019;23:5113-5121.
    Abstract    

    Abstract available

  76. WEI H, He WR, Chen KM, Wang XW, et al
    MiR-101 affects proliferation and apoptosis of cervical cancer cells by inhibition of JAK2.
    Eur Rev Med Pharmacol Sci. 2019;23:5640-5647.
    Abstract    

    Abstract available

  77. LIU CQ, Chen Y, Xie BF, Li YL, et al
    MicroRNA-215-3p suppresses the growth and metastasis of cervical cancer cell via targeting SOX9.
    Eur Rev Med Pharmacol Sci. 2019;23:5628-5639.
    Abstract    

    Abstract available

  78. YU Y, Zhao JD, Yang H
    MiR-299-3p inhibits proliferation and invasion of cervical cancer cell via targeting TCF4.
    Eur Rev Med Pharmacol Sci. 2019;23:5621-5627.
    Abstract    

    Abstract available

  79. LIU CN, Zhang HY, Liu CL, Wang CC, et al
    Upregulation of lncRNA CALML3-AS1 promotes cell proliferation and metastasis in cervical cancer via activation of the Wnt/beta-catenin pathway.
    Eur Rev Med Pharmacol Sci. 2019;23:5611-5620.
    Abstract    

    Abstract available

  80. ALLAIRE BT, Ekweme D, Hoerger TJ, DeGroff A, et al
    Cost-effectiveness of patient navigation for breast cancer screening in the National Breast and Cervical Cancer Early Detection Program.
    Cancer Causes Control. 2019 Jul 11. pii: 10.1007/s10552-019-01200.
    Abstract    

    Abstract available

  81. LIU JJ, Ho JY, Lee HW, Baik MW, et al
    Inhibition of Phosphatidylinositol 3-kinase (PI3K) Signaling Synergistically Potentiates Antitumor Efficacy of Paclitaxel and Overcomes Paclitaxel-Mediated Resistance in Cervical Cancer.
    Int J Mol Sci. 2019;20.
    Abstract    

    Abstract available

  82. WANG MZ, Feng RM, Wang S, Duan XZ, et al
    Clinical Performance of Human Papillomavirus Testing and Visual Inspection With Acetic Acid in Primary, Combination, and Sequential Cervical Cancer Screening in China.
    Sex Transm Dis. 2019;46:540-547.
    Abstract    

    Abstract available

  83. FLORES BE, Acton G, Arevalo-Flechas L, Gill S, et al
    Health Literacy and Cervical Cancer Screening Among Mexican-American Women.
    Health Lit Res Pract. 2019;3:e1-e8.
    Abstract    

    Abstract available

  84. WANG Y, Liu L, Chen Z
    Transcriptome profiling of cervical cancer cells acquired resistance to cisplatin by deep sequencing.
    Artif Cells Nanomed Biotechnol. 2019;47:2820-2829.
    Abstract    

    Abstract available

  85. NUMATA T, Sato-Numata K, Okada Y
    TRPM7 is involved in acid-induced necrotic cell death in a manner sensitive to progesterone in human cervical cancer cells.
    Physiol Rep. 2019;7:e14157.
    Abstract    

    Abstract available

  86. LOPES AC, Bacalhau R, Santos M, Pereira M, et al
    Contribution of Sociodemographic, Clinical, and Psychological Variables to Quality of Life in Women with Cervical Cancer in the Follow-Up Phase.
    J Clin Psychol Med Settings. 2019 Jul 10. pii: 10.1007/s10880-019-09644.
    Abstract    

    Abstract available

  87. TEIXEIRA C, Pereira AM, Anes E, Rodrigues C, et al
    [Time-Trends in Cervical Cancer Mortality in Portugal].
    Acta Med Port. 2019;32:427-433.
    Abstract    

    Abstract available

  88. LIN W, Wang Y, Liu Z, Chen B, et al
    Inequalities in Awareness and Attitude towards HPV and Its Vaccine between Local and Migrant Residents Who Participated in Cervical Cancer Screening in Shenzhen, China.
    Cancer Res Treat. 2019 Jul 1. pii: crt.2019.053. doi: 10.4143/crt.2019.
    Abstract    

    Abstract available

  89. RIBEIRO CM, Dias MBK, Pla MAS, Correa FM, et al
    [Parameters for programming line of care procedures for cervical cancer in Brazil].
    Cad Saude Publica. 2019;35:e00183118.
    Abstract    

    Abstract available

  90. WANG X, Wang L, Zong S, Qiu R, et al
    Use of multifunctional composite nanofibers for photothermalchemotherapy to treat cervical cancer in mice.
    Biomater Sci. 2019 Jul 10. doi: 10.1039/c9bm00756.
    Abstract    

    Abstract available

  91. ALIWAINI S, Awadallah AM, Morjan RY, Ghunaim M, et al
    Novel imidazo[1,2-a]pyridine inhibits AKT/mTOR pathway and induces cell cycle arrest and apoptosis in melanoma and cervical cancer cells.
    Oncol Lett. 2019;18:830-837.
    Abstract    

    Abstract available

  92. XU ML, Kim HJ, Kim SC, Ju W, et al
    Serum anti-GAPDH autoantibody levels reflect the severity of cervical lesions: A potential serum biomarker for cervical cancer screening.
    Oncol Lett. 2019;18:255-264.
    Abstract    

    Abstract available

  93. ORGANISTA-NAVA J, Gomez-Gomez Y, Garibay-Cerdenares OL, Leyva-Vazquez MA, et al
    Cervical cancer stem cell-associated genes: Prognostic implications in cervical cancer.
    Oncol Lett. 2019;18:7-14.
    Abstract    

    Abstract available

  94. HAN L, Husaiyin S, Ma C, Wang L, et al
    TNFAIP8L1 and FLT1 Polymorphisms Alter the Susceptibility to Cervical Cancer among Uyghur Females in China.
    Biosci Rep. 2019 Jul 9. pii: BSR20191155. doi: 10.1042/BSR20191155.
    Abstract    

    Abstract available

  95. CUSIMANO MC, Baxter NN, Gien LT, Moineddin R, et al
    Impact of Surgical Approach on Oncologic Outcomes in Women Undergoing Radical Hysterectomy for Cervical Cancer.
    Am J Obstet Gynecol. 2019 Jul 6. pii: S0002-9378(19)30893.
    Abstract    

    Abstract available

  96. TAPERA O, Dreyer G, Kadzatsa W, Nyakabau AM, et al
    Cervical cancer knowledge, attitudes, beliefs and practices of women aged at least 25 years in Harare, Zimbabwe.
    BMC Womens Health. 2019;19:91.
    Abstract    

    Abstract available

  97. HOU Y, Guo S, Lyu J, Lu Z, et al
    Prognostic factors in Asian and white American patients with cervical cancer, considering competing risks.
    Curr Oncol. 2019;26:e277-e285.
    Abstract    

    Abstract available

  98. FANI M, Mahmoodi P, Emadzadeh M, Avan A, et al
    Correlation of human papillomavirus 16 and 18 with cervical cancer and their diagnosis methods in Iranian women: A systematic review and meta-analysis.
    Curr Probl Cancer. 2019 Jul 2. pii: S0147-0272(18)30478.
    Abstract    

    Abstract available

  99. WANG Q, Steger A, Mahner S, Jeschke U, et al
    The Formation and Therapeutic Update of Tumor-Associated Macrophages in Cervical Cancer.
    Int J Mol Sci. 2019;20.
    Abstract    

    Abstract available

  100. ZHEN HN, Miao Z, Lian X, Hu K, et al
    [Information Needs and Quality among Cervical Cancer Patients].
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao. 2019;41:388-395.
    Abstract    

    Abstract available

  101. TIAN Q, Liu J, Xia S, Wang L, et al
    Association between HPV16 infection and expression of ERK12 signaling pathway in cervical cancer.
    Minerva Med. 2019 Jul 5. pii: S0026-4806.19.06183.
    Abstract    



  102. GIAVEDONI ME, Staringer L, Garrido R, Bertoncini C, et al
    Experience with concurrent chemoradiotherapy treatment in advanced cervical cancer: results from a hospital in Argentina.
    Ecancermedicalscience. 2019;13:919.
    Abstract    

    Abstract available

  103. MACEDO ACL, Goncalves JCN, Bavaresco DV, Grande AJ, et al
    Accuracy of mRNA HPV Tests for Triage of Precursor Lesions and Cervical Cancer: A Systematic Review and Meta-Analysis.
    J Oncol. 2019;2019:6935030.
    Abstract    

    Abstract available

  104. OLIVEIRA CR, Hosier H, Pate B, Niccolai LM, et al
    Compliance with Cervical Cancer Screening Guidelines in Young Females: Rates and Trends of Screening in New Haven County, CT.
    Am J Obstet Gynecol. 2019 Jul 4. pii: S0002-9378(19)30886.
    Abstract    



  105. BANERJEE S, Karunagaran D
    An integrated approach for mining precise RNA-based cervical cancer staging biomarkers.
    Gene. 2019;712:143961.
    Abstract    

    Abstract available

  106. PANDEY NO, Chauhan AV, Raithatha NS, Patel PK, et al
    Association of TLR4 and TLR9 polymorphisms and haplotypes with cervical cancer susceptibility.
    Sci Rep. 2019;9:9729.
    Abstract    

    Abstract available

  107. GABAZA C, Chonzi P, Chadambuka A, Shambira G, et al
    Utilization and outcomes of cervical cancer screening services in Harare City, 2012-2016: a secondary data analysis.
    BMC Health Serv Res. 2019;19:454.
    Abstract    

    Abstract available

  108. LIN CH, Peng SF, Chueh FS, Cheng ZY, et al
    The Ethanol Crude Extraction of Cyperus Rotundus Regulates Apoptosis-associated Gene Expression in HeLa Human Cervical Carcinoma Cells In Vitro.
    Anticancer Res. 2019;39:3697-3709.
    Abstract    

    Abstract available

  109. OU ZJ, Zhao D, An JS, Sun CY, et al
    [Analysis of prognostic factors and therapeutic patterns of recurrent stage b-a cervical squamous carcinoma treated with radical hysterectomy].
    Zhonghua Fu Chan Ke Za Zhi. 2019;54:399-405.
    Abstract    

    Abstract available

  110. CAO QW, You ZX, Qian XY, Heng D, et al
    [Discussion on the diagnosis and treatment of high-grade squamous intraepithelial lesions in post-menopausal women].
    Zhonghua Fu Chan Ke Za Zhi. 2019;54:393-398.
    Abstract    

    Abstract available

  111. CHAO YS, Clark M, Carson E, Weeks L, et al
    Metastatic cervical carcinoma to the thyroid gland: A rare diagnosis.
    Taiwan J Obstet Gynecol. 2019;58:298-299.
    Abstract    

    Abstract available

  112. SCHAFFER P, Batash R, Ertl-Wagner B, Hofstetter A, et al
    Treatment of cervix carcinoma FIGO IIIb with Photofrin II as a radiosensitizer: a case report.
    Photochem Photobiol Sci. 2019;18:1275-1279.
    Abstract    

    Abstract available

  113. HE Y, Xu L, Feng M, Wang W, et al
    Role of CD97 small isoform in human cervical carcinoma.
    Int J Exp Pathol. 2019;100:19-24.
    Abstract    

    Abstract available

  114. FITZPATRICK MB, Dube Mandishora RS, Katzenstein DA, McCarty K, et al
    hrHPV prevalence and type distribution in rural Zimbabwe: A community-based self-collection study using near-point-of-care GeneXpert HPV testing.
    Int J Infect Dis. 2019;82:21-29.
    Abstract    

    Abstract available

  115. GHOSH D, Roy AK, Murmu N, Mandal S, et al
    Risk Categorization with Different Grades of Cervical Pre-Neoplastic Lesions - High Risk HPV Associations and Expression of p53 and RARbeta
    Asian Pac J Cancer Prev. 2019;20:549-555.
    Abstract    

    Abstract available

  116. INOUE S, Ito H, Hosono S, Hori M, et al
    Net Survival of Elderly Patients with Gynecological Cancer Aged Over 75 Years in 2006-2008
    Asian Pac J Cancer Prev. 2019;20:437-442.
    Abstract    

    Abstract available

  117. AYDOGMUS H, Aydogmus S
    Comparison of Colposcopic Biopsy Results of Patients Who have Cytomorphological Normal but HPV 16-18 or Other High-Risk HPV Subtypes Positive
    Asian Pac J Cancer Prev. 2019;20:417-420.
    Abstract    

    Abstract available

  118. SHANKAR A, Patil J, Sethi N, Chakraborty A, et al
    Urinary Dysfunction Assessment in Long-Term Survivors of Carcinoma Cervix Using LENT SOMA Scale: An Indian Study Addressing Quality of Life Issues
    Asian Pac J Cancer Prev. 2019;20:383-389.
    Abstract    

    Abstract available

  119. SRISOMBOON S, Tantipalakorn C, Charoenkwan K, Srisomboon J, et al
    Cervical Screening Results Leading to Detection of Adenocarcinoma in Situ of the Uterine Cervix
    Asian Pac J Cancer Prev. 2019;20:377-382.
    Abstract    

    Abstract available

  120. WIIK J, Sengpiel V, Kyrgiou M, Nilsson S, et al
    Cervical microbiota in women with cervical intra-epithelial neoplasia, prior to and after local excisional treatment, a Norwegian cohort study.
    BMC Womens Health. 2019;19:30.
    Abstract    

    Abstract available

  121. CHRISTENSEN JT, Gronhoj C, Zamani M, Brask J, et al
    Association between oropharyngeal cancers with known HPV and p16 status and cervical intraepithelial neoplasia: a Danish population-based study.
    Acta Oncol. 2019;58:267-272.
    Abstract    

    Abstract available

  122. SHUKLA AK, Rana BS, Singh NP, Kumar S, et al
    Dosimetric study of CO-60 source step size in uterine cervix intracavitary HDR brachytherapy.
    Brachytherapy. 2019;18:180-185.
    Abstract    

    Abstract available

  123. DA SILVA VTM, Fortuna Diniz AP, Martins J, Cursino K, et al
    Use of interstitial brachytherapy in pelvic recurrence of cervical carcinoma: Clinical response, survival, and toxicity.
    Brachytherapy. 2019;18:146-153.
    Abstract    

    Abstract available

  124. WU PY, Wong TPW, Yip YYC, Chang TYA, et al
    MRI-guided adaptive brachytherapy for locally advanced cervix cancer: Treatment outcomes from a single institution in Hong Kong.
    Brachytherapy. 2019;18:171-179.
    Abstract    

    Abstract available

  125. LIN AJ, Hassanzadeh C, Markovina S, Schwarz J, et al
    Brachytherapy and survival in small cell cancer of the cervix and uterus.
    Brachytherapy. 2019;18:163-170.
    Abstract    

    Abstract available

  126. JIANG Z, Albanese J, Kesterson J, Warrick J, et al
    Monoclonal Antibodies Against Human Papillomavirus E6 and E7 Oncoproteins Inhibit Tumor Growth in Experimental Cervical Cancer.
    Transl Oncol. 2019;12:1289-1295.
    Abstract    

    Abstract available

  127. PICHLIK T, Rob L, Robova H, Halaska MJ, et al
    Individualization of surgical management of cervical cancer stages IA1, IA2.
    Ceska Gynekol. 2019;84:172-176.
    Abstract    

    Abstract available

  128. MARRET G, Borcoman E, Le Tourneau C
    Pembrolizumab for the treatment of Cervical Cancer.
    Expert Opin Biol Ther. 2019 Jul 19. doi: 10.1080/14712598.2019.1646721.
    Abstract    

    Abstract available

  129. ZHU P, Tan Q, Jiang W, Ou Y, et al
    Eukaryotic translation initiation factor 3B is overexpressed and correlates with higher FIGO stage III/IV, lymph node metastasis and unfavorable survival profiles in cervical cancer patients.
    Cancer Biomark. 2019 Jul 10. pii: CBM182114. doi: 10.3233/CBM-182114.
    Abstract    

    Abstract available

  130. WANG C, Zou H, Yang H, Wang L, et al
    Long noncoding RNA plasmacytoma variant translocation 1 gene promotes the development of cervical cancer via the NFkappaB pathway.
    Mol Med Rep. 2019 Jul 9. doi: 10.3892/mmr.2019.10479.
    Abstract    

    Abstract available

  131. CHIZENGA EP, Chandran R, Abrahamse H
    Photodynamic therapy of cervical cancer by eradication of cervical cancer cells and cervical cancer stem cells.
    Oncotarget. 2019;10:4380-4396.
    Abstract    

    Abstract available

  132. SUN Y, Feng Y, Zhang G, Xu Y, et al
    The endonuclease APE1 processes miR-92b formation, thereby regulating expression of the tumor suppressor LDLR in cervical cancer cells.
    Ther Adv Med Oncol. 2019;11:1758835919855859.
    Abstract    

    Abstract available

  133. ZHANG J, Gao Y
    Long non-coding RNA MEG3 inhibits cervical cancer cell growth by promoting degradation of P-STAT3 protein via ubiquitination.
    Cancer Cell Int. 2019;19:175.
    Abstract    

    Abstract available

  134. FOKOM DOMGUE J, Cunningham SA, Yu RK, Shete S, et al
    Prevalence and determinants of cervical cancer screening with a combination of cytology and human papillomavirus testing.
    Ann Epidemiol. 2019 Jun 21. pii: S1047-2797(19)30135.
    Abstract    

    Abstract available

  135. LORENZI NPC, Termini L, Longatto Filho A, Tacla M, et al
    Age-related acceptability of vaginal self-sampling in cervical cancer screening at two university hospitals: a pilot cross-sectional study.
    BMC Public Health. 2019;19:963.
    Abstract    

    Abstract available

  136. BALASUBRAMANIAM SD, Balakrishnan V, Oon CE, Kaur G, et al
    Key Molecular Events in Cervical Cancer Development.
    Medicina (Kaunas). 2019;55.
    Abstract    

    Abstract available

  137. MA J, Yu L, Xu F, Yi H, et al
    Treatment and clinical outcomes of cervical cancer during pregnancy.
    Ann Transl Med. 2019;7:241.
    Abstract    

    Abstract available

  138. SUN Y, Cheng Y, Zhang Y, Han K, et al
    MicroRNA-889-3p targets FGFR2 to inhibit cervical cancer cell viability and invasion.
    Exp Ther Med. 2019;18:1440-1448.
    Abstract    

    Abstract available

  139. CHEN Z, Zhu Y, Du R, Pang N, et al
    Role of Regulatory B Cells in the Progression of Cervical Cancer.
    Mediators Inflamm. 2019;2019:6519427.
    Abstract    

    Abstract available

  140. ASGARY R, Cole H, Adongo P, Nwameme A, et al
    Acceptability and implementation challenges of smartphone-based training of community health nurses for visual inspection with acetic acid in Ghana: mHealth and cervical cancer screening.
    BMJ Open. 2019;9:e030528.
    Abstract    

    Abstract available

  141. YORUK S, Acikgoz A, Turkmen H, Ergor G, et al
    Risk factors and relationship between screening periodicity and risk of cervical cancer among nurses and midwives. A cross-sectional study.
    Sao Paulo Med J. 2019;137:119-125.
    Abstract    

    Abstract available

  142. OGDEN SN, Glanz K, Schapira MM, Bocage C, et al
    Patient Perspectives on Primary HPV Testing for Routine Cervical Cancer Screening.
    J Gen Intern Med. 2019 Jul 16. pii: 10.1007/s11606-019-05175.
    Abstract    



  143. GEETHA R, Sivasubramanian S, Kaliappan M, Vimal S, et al
    Cervical Cancer Identification with Synthetic Minority Oversampling Technique and PCA Analysis using Random Forest Classifier.
    J Med Syst. 2019;43:286.
    Abstract    

    Abstract available

  144. WU MF, Guan MM, Liu CH, Wu JY, et al
    The added value of fasting blood glucose to serum squamous cell carcinoma antigen for predicting oncological outcomes in cervical cancer patients receiving neoadjuvant chemotherapy followed by radical hysterectomy.
    Cancer Med. 2019 Jul 16. doi: 10.1002/cam4.2414.
    Abstract    

    Abstract available

  145. KUEHN B
    Reducing Cervical Cancer Deaths.
    JAMA. 2019;322:198.
    Abstract    



  146. CHEN T, Wei M, Liu Y, Wang H, et al
    Rising Mortality Rate of Cervical Cancer in Younger Women in Urban China.
    J Gen Intern Med. 2019 Jul 15. pii: 10.1007/s11606-019-05174.
    Abstract    



  147. LI L, Wu M, Ma S, Tan X, et al
    Neoadjuvant chemotherapy followed by radical hysterectomy for stage IB2-to-IIB cervical cancer: a retrospective cohort study.
    Int J Clin Oncol. 2019 Jul 15. pii: 10.1007/s10147-019-01510.
    Abstract    

    Abstract available

  148. VOJTISEK R, Sukovska E, Baxa J, Budikova M, et al
    Late side effects of 3T MRI-guided 3D high-dose rate brachytherapy of cervical cancer : Institutional experiences.
    Strahlenther Onkol. 2019 Jul 15. pii: 10.1007/s00066-019-01491.
    Abstract    

    Abstract available

  149. RUNGE AS, Bernstein ME, Lucas AN, Tewari KS, et al
    Cervical cancer in Tanzania: A systematic review of current challenges in six domains.
    Gynecol Oncol Rep. 2019;29:40-47.
    Abstract    

    Abstract available

  150. KRAUT RY
    Starting cervical cancer screening at 25 years of age.
    CMAJ. 2019;191:E797.
    Abstract    



  151. WINER R, Tiro JA, Miglioretti DL, Thayer C, et al
    Corrigendum to "Rationale and design of the HOME trial: A pragmatic randomized controlled trial of home-based human papillomavirus (HPV) self-sampling for increasing cervical cancer screening uptake and effectiveness in a U.S. healthcare system" [Cont
    Contemp Clin Trials. 2019 Jul 13:105811. doi: 10.1016/j.cct.2019.
    Abstract    



  152. NUTTHACHOTE P, Oranratanaphan S, Termrungruanglert W, Triratanachat S, et al
    Comparison of detection rate of high risk HPV infection between self-collected HPV testing and clinician-collected HPV testing in cervical cancer screening.
    Taiwan J Obstet Gynecol. 2019;58:477-481.
    Abstract    

    Abstract available

  153. XU C, Sun H, Du S, Xin J, et al
    Early treatment response of patients undergoing concurrent chemoradiotherapy for cervical cancer: An evaluation of integrated multi-parameter PET-IVIM MR.
    Eur J Radiol. 2019;117:1-8.
    Abstract    

    Abstract available

  154. POTOCNJAK I, Simic L, Vukelic I, Domitrovic R, et al
    Oleanolic acid attenuates cisplatin-induced nephrotoxicity in mice and chemosensitizes human cervical cancer cells to cisplatin cytotoxicity.
    Food Chem Toxicol. 2019;132:110676.
    Abstract    

    Abstract available

  155. WU Y, Zhao J, Dong S, Wang Y, et al
    Whole-exome and RNA sequencing reveals novel insights into the pathogenesis of HPV associated cervical cancer.
    Cancer Biomark. 2019 Jun 27. pii: CBM190055. doi: 10.3233/CBM-190055.
    Abstract    

    Abstract available

  156. BUS-KWOFIE A, Chan C, Kahn R, Holcomb K, et al
    Clinical Controversies in Cervical Cancer Screening.
    Clin Obstet Gynecol. 2019 Jul 11. doi: 10.1097/GRF.0000000000000478.
    Abstract    

    Abstract available

  157. DENG YR, Chen XJ, Chen W, Wu LF, et al
    Sp1 contributes to radioresistance of cervical cancer through targeting G2/M cell cycle checkpoint CDK1.
    Cancer Manag Res. 2019;11:5835-5844.
    Abstract    

    Abstract available

  158. CHAY DB, Han GH, Nam S, Cho H, et al
    Forkhead box protein O1 (FOXO1) and paired box gene 3 (PAX3) overexpression is associated with poor prognosis in patients with cervical cancer.
    Int J Clin Oncol. 2019 Jul 13. pii: 10.1007/s10147-019-01507.
    Abstract    

    Abstract available

  159. NAMAZOV A, Volchok V, Liboff A, Volodarsky M, et al
    Sentinel Nodes Detection with Near-infrared Imaging in Gynecological Cancer Patients: Ushering in an Era of Precision Medicine.
    Isr Med Assoc J. 2019;21:390-393.
    Abstract    

    Abstract available

  160. WANG SF, Bu QW, Zhang L, Ma JW, et al
    [Detection and analysis of FAM19A4 promoter methylation in cervical exfoliated cells].
    Zhonghua Yi Xue Za Zhi. 2019;99:1963-1967.
    Abstract    

    Abstract available

  161. NIIKURA H, Tsuji K, Tokunaga H, Shimada M, et al
    Sentinel node navigation surgery in cervical and endometrial cancer: a review.
    Jpn J Clin Oncol. 2019;49:495-500.
    Abstract    

    Abstract available

  162. LIU CR, Liang H, Zhang X, Pu C, et al
    Effect of an educational intervention on HPV knowledge and attitudes towards HPV and its vaccines among junior middle school students in Chengdu, China.
    BMC Public Health. 2019;19:488.
    Abstract    

    Abstract available

  163. RATREE S, Kleebkaow P, Aue-Aungkul A, Temtanakitpaisan A, et al
    Histopathology of Women with "Atypical Squamous Cells Cannot Exclude High-Grade Squamous Intraepithelial Lesion" (ASC-H) Smears
    Asian Pac J Cancer Prev. 2019;20:683-686.
    Abstract    

    Abstract available

  164. MAKK E, Balint L, Cifra J, Tornoczky T, et al
    Robust expression of EZH2 in endocervical neoplastic lesions.
    Virchows Arch. 2019;475:95-104.
    Abstract    

    Abstract available

  165. NADERI J, Samani F, Amooheidari A, Javanmard SH, et al
    Evaluation of effects of morphine and ionizing radiation in cancer cell lines.
    J Cancer Res Ther. 2019;15.
    Abstract    

    Abstract available

  166. PALUKU JL, Carter TE, Lee M, Bartels SA, et al
    Massive single visit cervical pre-cancer and cancer screening in eastern Democratic Republic of Congo.
    BMC Womens Health. 2019;19:43.
    Abstract    

    Abstract available

  167. BUNYATYAN ND, Oborotova NA, Nikolaeva LL, Saprykina NS, et al
    Comparative Analysis of Bioactivity of the Russian-Made Antitumor Substances of the Nitrosourea Group.
    Bull Exp Biol Med. 2019;166:456-460.
    Abstract    

    Abstract available

  168. MARLOW L, McBride E, Varnes L, Waller J, et al
    Barriers to cervical screening among older women from hard-to-reach groups: a qualitative study in England.
    BMC Womens Health. 2019;19:38.
    Abstract    

    Abstract available

  169. GARCIA-MORENO M, Noerenberg M, Ni S, Jarvelin AI, et al
    System-wide Profiling of RNA-Binding Proteins Uncovers Key Regulators of Virus Infection.
    Mol Cell. 2019;74:196-211.
    Abstract    

    Abstract available

  170. KOVACEVIC G, Milosevic V, Knezevic P, Knezevic A, et al
    Prevalence of oncogenic Human papillomavirus and genetic diversity in the L1 gene of HPV16 HPV 18 HPV31 and HPV33 found in women from Vojvodina Province Serbia.
    Biologicals. 2019;58:57-63.
    Abstract    

    Abstract available

  171. ABEDIN S, Paul SK, Haque N, Ahmed S, et al
    Distribution of HPV-16 and HPV-18 from the Patients Attending At Mymensingh Medical College Hospital by Newly Developed Oncoprotein Detection Assay.
    Mymensingh Med J. 2019;28:31-36.
    Abstract    

    Abstract available

  172. SPELLUN AH, Moreland CJ, Kushalnagar P
    Young Deaf Adults' Knowledge of Human Papillomavirus and Human Papillomavirus Vaccine's Effectiveness in Preventing Cervical, Anal, Penile, and Oral Cancer.
    J Pediatr Adolesc Gynecol. 2019;32:293-299.
    Abstract    

    Abstract available

  173. WINATA IGS, Hidayat YM, Winarno GN, Suardi D, et al
    Pulsatility Index and Hypoxia Inducible Factor-1alpha Expression Predict the Clinical Response after External Radiation in Patients with Stage IIB to IVA Cervical Cancer.
    Asian Pac J Cancer Prev. 2019;20:2073-2078.
    Abstract    

    Abstract available

  174. TAMURA K, Hasegawa K, Katsumata N, Matsumoto K, et al
    Efficacy and safety of nivolumab in Japanese patients with uterine cervical cancer, uterine corpus cancer, or soft tissue sarcoma: a multicenter, open-label phase 2 trial.
    Cancer Sci. 2019 Jul 26. doi: 10.1111/cas.14148.
    Abstract    

    Abstract available

  175. YANG J, Cai H, Xiao ZX, Wang H, et al
    Effect of radiotherapy on the survival of cervical cancer patients: An analysis based on SEER database.
    Medicine (Baltimore). 2019;98:e16421.
    Abstract    

    Abstract available

  176. CEGLA P, Burchardt E, Roszak A, Czepczynski R, et al
    Influence of Biological Parameters Assessed in [18F]FDG PET/CT on Overall Survival in Cervical Cancer Patients.
    Clin Nucl Med. 2019 Jul 24. doi: 10.1097/RLU.0000000000002733.
    Abstract    

    Abstract available

  177. ZHOU P, Chen D, Shi L
    Cervical Cancer Mortality in Younger Women.
    J Gen Intern Med. 2019 Jul 25. pii: 10.1007/s11606-019-05183.
    Abstract    



  178. SAGI-DAIN L, Abol-Fol S, Lavie O, Sagi S, et al
    Cervical Cancer with Intermediate Risk Factors: Is there a Role for Adjuvant Radiotherapy? A Systematic Review and a Meta-Analysis.
    Gynecol Obstet Invest. 2019 Jul 25:1-10. doi: 10.1159/000501683.
    Abstract    

    Abstract available

  179. SEDANI A, Soliman AS, Msami K, Msemo D, et al
    Impact of Initiating Screening Programs on Referral and Management of Cervical Cancer in Tanzania.
    J Glob Oncol. 2019;5:JGO1800052.
    Abstract    

    Abstract available

  180. DE BOER P, Spijkerboer AM, Bleeker MCG, van Lonkhuijzen LRCW, et al
    Prospective validation of craniocaudal tumour size on MR imaging compared to histoPAthology in patients with uterine cervical cancer: The MPAC study.
    Clin Transl Radiat Oncol. 2019;18:9-15.
    Abstract    

    Abstract available

  181. ANFINAN N
    Cervical Cancer Staging in Saudi Arabia Clinicoradiological Correlation.
    Biomed Res Int. 2019;2019:8745828.
    Abstract    

    Abstract available

  182. BERNARDES-OLIVEIRA E, Farias KJS, Gomes DL, de Araujo JMG, et al
    Tityus serrulatus Scorpion Venom Induces Apoptosis in Cervical Cancer Cell Lines.
    Evid Based Complement Alternat Med. 2019;2019:5131042.
    Abstract    

    Abstract available

  183. YAO Y, Yan Z, Dai S, Li C, et al
    Human Papillomavirus Type 16 E1 Mutations Associated with Cervical Cancer in a Han Chinese Population.
    Int J Med Sci. 2019;16:1042-1049.
    Abstract    

    Abstract available

  184. SONG T, Seong SJ, Lee SK, Kim BR, et al
    Searching for an ideal cervical cancer screening model to reduce false-negative errors in a country with high prevalence of cervical cancer.
    J Obstet Gynaecol. 2019 Jul 25:1-7. doi: 10.1080/01443615.2019.1621813.
    Abstract    

    Abstract available

  185. DUENAS-GONZALEZ A, Gonzalez-Fierro A
    Pharmacodynamics of current and emerging treatments for cervical cancer.
    Expert Opin Drug Metab Toxicol. 2019 Jul 25. doi: 10.1080/17425255.2019.1648431.
    Abstract    

    Abstract available

  186. NING YE, Liu Y, Xu XY, Zhang XY, et al
    Knowledge of Cervical Cancer, Human Papilloma Virus (HPV) and HPV Vaccination Among Women in Northeast China.
    J Cancer Educ. 2019 Jul 24. pii: 10.1007/s13187-019-01582.
    Abstract    

    Abstract available

  187. WU X, Peng L, Zhang Y, Chen S, et al
    Identification of Key Genes and Pathways in Cervical Cancer by Bioinformatics Analysis.
    Int J Med Sci. 2019;16:800-812.
    Abstract    

    Abstract available

  188. NG SC, Wang PH, Lee YC, Lee CY, et al
    Impact of matrix metalloproteinase-11 gene polymorphisms on development and clinicopathologcial variables of uterine cervical cancer in Taiwanese women.
    Int J Med Sci. 2019;16:774-782.
    Abstract    

    Abstract available

  189. GIZAW M, Teka B, Ruddies F, Abebe T, et al
    Uptake of cervical cancer screening in Ethiopia by self-sampling HPV DNA compared to visual inspection with acetic acid: a cluster randomized trial.
    Cancer Prev Res (Phila). 2019 Jul 23. pii: 1940-6207.CAPR-19-0156.
    Abstract    

    Abstract available

  190. CHEN M, Li L, Zheng PS
    SALL4 promotes the tumorigenicity of cervical cancer cells through activation of Wnt/beta-catenin pathway via CTNNB1.
    Cancer Sci. 2019 Jul 23. doi: 10.1111/cas.14140.
    Abstract    

    Abstract available

  191. WANG SX, Wu JL, Zheng RM, Xiong WY, et al
    A preliminary cervical cancer screening cascade for eight provinces rural Chinese women: a descriptive analysis of cervical cancer screening cases in a 3-stage framework.
    Chin Med J (Engl). 2019 Jul 22. doi: 10.1097/CM9.0000000000000353.
    Abstract    

    Abstract available

  192. ZHANG C, Gu L, Li X, Wang J, et al
    Silencing of Synuclein-gamma inhibits human cervical cancer through the AKT signaling pathway.
    Cell Mol Biol Lett. 2019;24:49.
    Abstract    

    Abstract available

  193. DE FOUW M, Kaba M, Hailu M, Bereket FZ, et al
    Local community networks in the fight against cervical cancer: the role of coffee ceremonies in the uptake of screening in Ethiopia.
    Trop Doct. 2019 Jul 23:49475519864763. doi: 10.1177/0049475519864763.
    Abstract    

    Abstract available

  194. LUO W, Wang M, Liu J, Cui X, et al
    Identification of a six lncRNAs signature as novel diagnostic biomarkers for cervical cancer.
    J Cell Physiol. 2019 Jul 22. doi: 10.1002/jcp.29015.
    Abstract    

    Abstract available

  195. HUI Y, Guo X
    TP73 is a credible biomarker for predicting clinical progression and prognosis in cervical cancer patients.
    Biosci Rep. 2019 Jul 22. pii: BSR20190095. doi: 10.1042/BSR20190095.
    Abstract    

    Abstract available

  196. OTTER SJ, Chatterjee J, Stewart AJ, Michael A, et al
    The Role of Biomarkers for the Prediction of Response to Checkpoint Immunotherapy and the Rationale for the Use of Checkpoint Immunotherapy in Cervical Cancer.
    Clin Oncol (R Coll Radiol). 2019 Jul 19. pii: S0936-6555(19)30283.
    Abstract    

    Abstract available

  197. YU H, Zhang L, Li D, Liu N, et al
    Postoperative adjuvant chemotherapy combined with intracavitary brachytherapy achieved the equivalent survival compared with concurrent chemoradiotherapy in cervical cancer patients with intermediate-risk.
    Jpn J Clin Oncol. 2019 Apr 24. pii: 5477439. doi: 10.1093.
    Abstract    

    Abstract available

  198. HRINIVICH WT, Morcos M, Viswanathan A, Lee J, et al
    Automatic tandem and ring reconstruction using MRI for cervical cancer brachytherapy.
    Med Phys. 2019 Jul 22. doi: 10.1002/mp.13730.
    Abstract    

    Abstract available

  199. KIM M, Kim YB, Kim JW
    After the Laparoscopic Approach to Cervical Cancer (LACC) trial: Korean Society of Gynecologic Oncology (KSGO) survey.
    J Gynecol Oncol. 2019;30:e108.
    Abstract    



  200. KIM M, Kong TW, Kim S, Kim SC, et al
    Minimally invasive surgery for radical hysterectomy in women with cervical cancer: Korean Society of Gynecologic Oncology, Korean Society of Obstetrics and Gynecology, and Korean Society of Gynecologic Endoscopy and Minimally Invasive Surgery position
    J Gynecol Oncol. 2019;30:e104.
    Abstract    

    Abstract available

  201. GUAN D, Li C, Lv X, Yang Y, et al
    Pseudolaric acid B inhibits PAX2 expression through Wnt signaling and induces BAX expression, therefore promoting apoptosis in HeLa cervical cancer cells.
    J Gynecol Oncol. 2019;30:e77.
    Abstract    

    Abstract available

  202. SHIN HY, Lee B, Hwang SH, Lee DO, et al
    Evaluation of satisfaction with three different cervical cancer screening modalities: clinician-collected Pap test vs. HPV test by self-sampling vs. HPV test by urine sampling.
    J Gynecol Oncol. 2019;30:e76.
    Abstract    

    Abstract available

  203. KIM YJ, Han S, Kim YS, Nam JH, et al
    Prognostic value of post-treatment (1)(8)F-fluorodeoxyglucose positron emission tomography in uterine cervical cancer patients treated with radiotherapy: a systematic review and meta-analysis.
    J Gynecol Oncol. 2019;30:e66.
    Abstract    

    Abstract available

  204. SCHMIDT SV, Seibert S, Walch-Ruckheim B, Vicinus B, et al
    Correction: RIPK3 expression in cervical cancer cells is required for PolyIC-induced necroptosis, IL-1alpha release, and efficient paracrine dendritic cell activation.
    Oncotarget. 2019;10:4503-4504.
    Abstract    

    Abstract available

  205. ZHANG W, Su X, Li S, Wang Y, et al
    Inhibiting MNK Selectively Targets Cervical Cancer via Suppressing eIF4E-Mediated beta-Catenin Activation.
    Am J Med Sci. 2019 Jun 5. pii: S0002-9629(19)30218.
    Abstract    

    Abstract available

  206. NKFUSAI NC, Mubah TM, Yankam BM, Tambe TA, et al
    Prevalence of precancerous cervical lesions in women attending Mezam Polyclinic Bamenda, Cameroon.
    Pan Afr Med J. 2019;32:174.
    Abstract    

    Abstract available

  207. NDOUR MA, Sow M, Thiam I, Djiba B, et al
    [Pseudotumoral tuberculosis of the cervix].
    Pan Afr Med J. 2019;32:163.
    Abstract    

    Abstract available

  208. OSIAGWU DD, Azenabor AE, Osijirin AA, Awopetu PI, et al
    Evaluation of interleukin 8 and interleukin 10 cytokines in liquid based cervical cytology samples.
    Pan Afr Med J. 2019;32:148.
    Abstract    

    Abstract available

  209. ZHOU H, Li Q, Wang T, Liang H, et al
    Prognostic biomarkers of cervical squamous cell carcinoma identified via plasma metabolomics.
    Medicine (Baltimore). 2019;98:e16192.
    Abstract    

    Abstract available

  210. BAPTISTA AD, Simao CX, Santos VCGD, Melgaco JG, et al
    Knowledge of human papillomavirus and Pap test among Brazilian university students.
    Rev Assoc Med Bras (1992). 2019;65:625-632.
    Abstract    

    Abstract available

  211. WEGWARTH O, Pashayan N, Widschwendter M, Rebitschek FG, et al
    Women's perception, attitudes, and intended behavior towards predictive epigenetic risk testing for female cancers in 5 European countries: a cross-sectional online survey.
    BMC Public Health. 2019;19:667.
    Abstract    

    Abstract available

  212. BAHENA M, Carvajal-Suarez M, Soliman AS, Luo J, et al
    The influence of medical providers on HPV vaccination among children of Mexican mothers: a comparison between Mexico and the Midwest region of the United States.
    BMC Public Health. 2019;19:515.
    Abstract    

    Abstract available

  213. YANG H, Pu H, Wang S, Ni R, et al
    Inequality of female health and its relation with urbanization level in China: geographic variation perspective.
    Environ Sci Pollut Res Int. 2019;26:16662-16673.
    Abstract    

    Abstract available

  214. ZHANG Q, Di C, Yan J, Wang F, et al
    Inhibition of SF3b1 by pladienolide B evokes cycle arrest, apoptosis induction and p73 splicing in human cervical carcinoma cells.
    Artif Cells Nanomed Biotechnol. 2019;47:1273-1280.
    Abstract    

    Abstract available

  215. LI H, Ruan WJ, Liu LQ, Wan HF, et al
    Impact of Taurine on the proliferation and apoptosis of human cervical carcinoma cells and its mechanism.
    Chin Med J (Engl). 2019;132:948-956.
    Abstract    

    Abstract available

  216. ZHANG X, Yang P, Luo X, Su C, et al
    High olive oil diets enhance cervical tumour growth in mice: transcriptome analysis for potential candidate genes and pathways.
    Lipids Health Dis. 2019;18:76.
    Abstract    

    Abstract available

  217. NING Y, Wang C, Liu X, Du Y, et al
    CK2-mediated CCDC106 phosphorylation is required for p53 degradation in cancer progression.
    J Exp Clin Cancer Res. 2019;38:131.
    Abstract    

    Abstract available

  218. LIM MC, Won YJ, Ko MJ, Kim M, et al
    Incidence of cervical, endometrial, and ovarian cancer in Korea during 1999-2015.
    J Gynecol Oncol. 2019;30:e38.
    Abstract    

    Abstract available

  219. TAKAHASHI K, Yunokawa M, Sasada S, Takehara Y, et al
    A novel prediction score for predicting the baseline risk of recurrence of stage I-II endometrial carcinoma.
    J Gynecol Oncol. 2019;30:e8.
    Abstract    

    Abstract available

  220. CHOI KH, Lee SW, Yu M, Jeong S, et al
    Significance of elevated SCC-Ag level on tumor recurrence and patient survival in patients with squamous-cell carcinoma of uterine cervix following definitive chemoradiotherapy: a multi-institutional analysis.
    J Gynecol Oncol. 2019;30:e1.
    Abstract    

    Abstract available

  221. RASK M, Swahnberg K, Oscarsson M
    Notification of an abnormal Pap smear result: An intervention study.
    Eur J Cancer Care (Engl). 2019;28:e12969.
    Abstract    

    Abstract available

  222. KLAPDOR R, Hertel H, Hillemanns P, Rottger M, et al
    Peritoneal contamination with ICG stained cervical secretion as surrogate for potential cervical cancer tumor cell dissemination. A proof-of-principle study for laparoscopic hysterectomy.
    Acta Obstet Gynecol Scand. 2019 Jun 26. doi: 10.1111/aogs.13681.
    Abstract    

    Abstract available

  223. WALLIN E, Falconer H, Floter Radestad A
    Sexual-, bladder-, bowel and ovarian function one year after robot-assisted radical hysterectomy for early stage cervical cancer.
    Acta Obstet Gynecol Scand. 2019 Jun 25. doi: 10.1111/aogs.13680.
    Abstract    

    Abstract available

  224. JORGENSEN SF, Njor SH
    Higher cervical cancer mortality among older women in Denmark could be due to insufficient screening coverage.
    Acta Obstet Gynecol Scand. 2019 Jul 19. doi: 10.1111/aogs.13685.
    Abstract    

    Abstract available

  225. LECAVALIER-BARSOUM M, Chaudary N, Han K, Pintilie M, et al
    Targeting CXCL12/CXCR4 and myeloid cells to improve the therapeutic ratio in patient-derived cervical cancer models treated with radio-chemotherapy.
    Br J Cancer. 2019 Jun 26. pii: 10.1038/s41416-019-0497.
    Abstract    

    Abstract available

  226. PRINTZ C
    HPV infections most often linked to cervical cancer have declined.
    Cancer. 2019;125:2336-2337.
    Abstract    



  227. LU D, Andrae B, Valdimarsdottir U, Sundstrom K, et al
    Psychological distress is associated with cancer-specific mortality among patients with cervical cancer.
    Cancer Res. 2019 Jun 28. pii: 0008-5472.CAN-19-0116.
    Abstract    

    Abstract available

  228. ARROYO-MUHR LS, Lagheden C, Hultin E, Eklund C, et al
    The HPV16 genome is stable in women who progress to in situ or invasive cervical cancer: a prospective population-based study.
    Cancer Res. 2019 Jul 9. pii: 0008-5472.CAN-18-3933.
    Abstract    

    Abstract available

  229. AYHAN A, Aslan K, Bulut AN, Akilli H, et al
    Is the revised 2018 FIGO staging system for cervical cancer more prognostic than the 2009 FIGO staging system for women previously staged as IB disease?
    Eur J Obstet Gynecol Reprod Biol. 2019;240:209-214.
    Abstract    

    Abstract available

  230. NAKAMURA M, Tanaka K, Hayashi S, Morisada T, et al
    Local anatomy around terminal ureter related to the anterior leaf of the vesicouterine ligament in radical hysterectomy.
    Eur J Obstet Gynecol Reprod Biol. 2019;235:66-70.
    Abstract    

    Abstract available

  231. PAIK ES, Lim MC, Kim MH, Kim YH, et al
    Comparison of laparoscopic and abdominal radical hysterectomy in early stage cervical cancer patients without adjuvant treatment: Ancillary analysis of a Korean Gynecologic Oncology Group Study (KGOG 1028).
    Gynecol Oncol. 2019 Jul 1. pii: S0090-8258(19)31339.
    Abstract    

    Abstract available

  232. RUENGKHACHORN I, Phithakwatchara N, Viriyapak B, Sangkarat S, et al
    Comparison of oncologic outcomes of unanticipated cervical carcinoma in women undergoing inadvertent simple hysterectomy and those undergoing surgical treatment after preoperative diagnosis.
    Gynecol Oncol. 2019 Mar 11. pii: S0090-8258(19)30135.
    Abstract    

    Abstract available

  233. WRIGHT TC JR, Parvu V, Stoler MH, Kodsi S, et al
    HPV infections and cytologic abnormalities in vaccinated women 21-34years of age: Results from the baseline phase of the Onclarity trial.
    Gynecol Oncol. 2019 Mar 7. pii: S0090-8258(19)30126.
    Abstract    

    Abstract available

  234. ALIMENA S, Yang DD, Melamed A, Mahal BA, et al
    Racial disparities in brachytherapy administration and survival in women with locally advanced cervical cancer.
    Gynecol Oncol. 2019 Jul 7. pii: S0090-8258(19)31338.
    Abstract    

    Abstract available

  235. SUZUKI K, Nagao S, Shibutani T, Yamamoto K, et al
    Phase II trial of paclitaxel, carboplatin, and bevacizumab for advanced or recurrent cervical cancer.
    Gynecol Oncol. 2019 Jul 5. pii: S0090-8258(19)31262.
    Abstract    

    Abstract available

  236. LIU B, Li L, Wang M, Wei L, et al
    Health-related quality of life in locally advanced cervical cancer patients treated with neoadjuvant therapy followed by radical surgery: A single-institutional retrospective study from a prospective database.
    Gynecol Oncol. 2019 Jul 12. pii: S0090-8258(19)31354.
    Abstract    

    Abstract available

  237. COLDMAN AJ, van Niekerk D, Krajden M, Smith LW, et al
    Disease Detection at the 48 Month Exit Round of the HPV FOCAL Cervical Cancer Screening Trial in Women Per-Protocol Eligible for Routine Screening.
    Int J Cancer. 2019 Jun 27. doi: 10.1002/ijc.32524.
    Abstract    

    Abstract available

  238. TAWE L, MacDuffie E, Narasimhamurthy M, Wang Q, et al
    Human Papillomavirus (HPV) Genotypes in Women with Invasive Cervical Cancer with and without Human Immunodeficiency Virus (HIV) Infection in Botswana.
    Int J Cancer. 2019 Jul 20. doi: 10.1002/ijc.32581.
    Abstract    

    Abstract available

  239. COLA E, Maziku D, Torelli GF, Fagotti A, et al
    Cervical cancer in Tosamaganga Hospital, Tanzania: difficulties and challenges in a low resource country setting.
    Int J Gynecol Cancer. 2019 Jul 19. pii: ijgc-2019-000505.
    Abstract    



  240. CARPENTER DJ, Jacobs CD, Wong TZ, Craciunescu O, et al
    Changes on mid-chemoradiotherapy FDG-PET/CT for cervical cancer are associated with prognosis.
    Int J Radiat Oncol Biol Phys. 2019 Jun 26. pii: S0360-3016(19)33394.
    Abstract    

    Abstract available

  241. WU Q, Wang S, Chen X, Wang Y, et al
    Radiomics analysis of magnetic resonance imaging improves diagnostic performance of lymph node metastasis in patients with cervical cancer.
    Radiother Oncol. 2019;138:141-148.
    Abstract    

    Abstract available

  242. ABU-SHAWER O, Abu-Shawer M, Hirmas N, Alhouri A, et al
    Hematologic markers of distant metastases and poor prognosis in gynecological cancers.
    BMC Cancer. 2019;19:141.
    Abstract    

    Abstract available

  243. KRINGS A, Dunyo P, Pesic A, Tetteh S, et al
    Characterization of Human Papillomavirus prevalence and risk factors to guide cervical cancer screening in the North Tongu District, Ghana.
    PLoS One. 2019;14:e0218762.
    Abstract    

    Abstract available

  244. ALLANSON ER, Powell A, Bulsara M, Lee HL, et al
    Morbidity after surgical management of cervical cancer in low and middle income countries: A systematic review and meta-analysis.
    PLoS One. 2019;14:e0217775.
    Abstract    

    Abstract available

  245. WEBB S, Kelly PJ, Wickliffe J, Ault K, et al
    Validating self-reported cervical cancer screening among women leaving jails.
    PLoS One. 2019;14:e0219178.
    Abstract    

    Abstract available

  246. YU W, Kou C, Bai W, Yu X, et al
    The diagnostic performance of PET/CT scans for the detection of para-aortic metastatic lymph nodes in patients with cervical cancer: A meta-analysis.
    PLoS One. 2019;14:e0220080.
    Abstract    

    Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Cervical Cancer is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design:


;